The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
At this year’s American Society of Clinical Oncology conference, drug industry executives and their allies continued to peddle misinformation about the Inflation Reduction Act, claiming the law will…
News May 31, 2024Common cancer treatments hit the market with exorbitant list prices that typically increase faster than the rate of inflation – placing a severe financial strain on patients.
News May 25, 2024On Tuesday, the Senate Judiciary Committee held a hearing on the anti-competitive tactics used by the pharmaceutical industry to block generic and biosimilar competition in order to keep drug prices high.
News May 21, 2024Chairman Durbin, Ranking Member Graham, members of the committee.
News May 17, 2024A major milestone was reached earlier this month as 12-year-old Kendric from Washington, D.C. became the first patient living with sickle cell to begin a Food and Drug Administration (FDA) approved…
News May 10, 2024As blockbuster drugs approach patent expiration, major pharmaceutical companies are deploying manipulative tactics to extend their monopoly pricing power and delay or prevent lower-cost competition.
News May 3, 2024Big Pharma’s bid to obstruct the implementation of the Medicare Negotiation program suffered a significant setback on Monday as a federal judge ruled against Bristol Myers Squibb and Janssen…
News Apr 26, 2024New lobbying disclosures show that Big Pharma increased their lobbying spending during the first three months of 2024 compared to the same period last year, to stop reforms that would lower drug prices.
News Apr 19, 2024Leading drug companies are going to great lengths to protect their profits at the expense of patients.
News Apr 12, 2024This year’s record investment in biotech companies directly contradicts the drug industry’s claims that the Inflation Reduction Act would stifle innovation and drug development.
